US equities
|
NVDA
$238.81
▲+2.08%
SPCX
$167.65
▲+5.47%
MU
$1,062.72
▼-1.13%
TSLA
$380.32
▲+2.63%
MSFT
$526.28
▲+1.69%
SNDK
$1,702.12
▼-1.04%
INTC
$116.81
▼-2.12%
META
$742.67
▲+2.00%
NVDA
$238.81
▲+2.08%
SPCX
$167.65
▲+5.47%
MU
$1,062.72
▼-1.13%
TSLA
$380.32
▲+2.63%
MSFT
$526.28
▲+1.69%
SNDK
$1,702.12
▼-1.04%
INTC
$116.81
▼-2.12%
META
$742.67
▲+2.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Articles published by Aptar Digital Health
Aptar Digital Health Partners with Enable Injections for enFuse® Companion Digital Solution
April 08, 2026
From
Aptar Digital Health
Via
Business Wire
Tickers
ATR
Aptar Digital Health Announces FDA 510(k) Clearance for HeroTracker® Sense, a Connected Add-On Device for Metered-Dose Inhalers
October 16, 2025
From
Aptar Digital Health
Via
Business Wire
Tickers
ATR
Aptar Digital Health Reports Positive Impact of iPUMP® on Sublingual Liquid Allergen Immunotherapy Adherence
April 14, 2025
From
Aptar Digital Health
Via
Business Wire
Aptar Digital Health Partners with the University of Geneva to Advance Migraine Research
November 21, 2024
From
Aptar Digital Health
Via
Business Wire
Aptar Digital Health Announces Asthma Clinical Study with Guy’s and St Thomas’ NHS Foundation Trust
September 05, 2024
From
Aptar Digital Health
Via
Business Wire
Aptar Digital Health Partners with SHL Medical to Optimize Patient Experience with Self-Injectable Therapies
June 10, 2024
From
Aptar Digital Health
Via
Business Wire
Aptar Digital Health and Iona Mind Announce Partnership to Deliver Scalable Mental Health Support to Chronic Disease Patients
May 29, 2024
From
Aptar Digital Health
Via
Business Wire
